MedAvail Holdings (MedAvail Holdings) Interest Expense : $-0.96 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. MedAvail Holdings's interest expense for the three months ended in Jun. 2023 was $ -0.15 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.96 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. MedAvail Holdings's Operating Income for the three months ended in Jun. 2023 was $ -4.45 Mil. MedAvail Holdings's Interest Expense for the three months ended in Jun. 2023 was $ -0.15 Mil. MedAvail Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MedAvail Holdings Interest Expense Historical Data

The historical data trend for MedAvail Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings Interest Expense Chart

MedAvail Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Interest Expense

-0.73

-1.24

-0.59

-1.17

MedAvail Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Interest Expense	Get a 7-Day Free Trial										-0.27	-0.32	-0.33	-0.17	-0.15

MedAvail Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.96 Mil.

MedAvail Holdings (OTCPK:MDVLQ) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MedAvail Holdings's Interest Expense for the three months ended in Jun. 2023 was $-0.15 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-4.45 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $2.06 Mil.

MedAvail Holdings's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

MedAvail Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

MedAvail Holdings (MedAvail Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (OTCPK:MDVLQ) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040

Website

https://www.medavail.com

MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.

Executives

Ramona Seabaugh	officer: Chief Financial Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Michael R Kramer	director	3910 BRICKWAY BLVD, SANTA ROSA CA 95403
Paul D Johnson	director	440 N BARRANCA AVE #3550, COVINA CA 91723
Glen D. Stettin	director	C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Mark Edward Doerr	director, officer: Chief Executive Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Abg Wtt-medavail Ltd	10 percent owner	15 QUEENS ROAD CENTRAL, UNIT 3002-3004, 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK, HONG KONG F4 0000000000
Redco Ii Master Fund, L.p.	director, 10 percent owner	ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129
Alyeska Fund Gp, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investments, Llc	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Anand Parekh	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Master Fund, L.p.	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Alyeska Investment Group, L.p.	10 percent owner	77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601
Steven Hess	officer: Executive Vice President	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4
Edwin Kilroy	director, officer: Chief Executive Officer	C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4